Susmed Inc

Susmed Inc has a highly liquid capital structure, with cash and equivalents amounting to ¥4,953,621,000, significantly exceeding its total liabilities of ¥319,675,000, resulting in a current ratio of 15.96. The company has no long-term debt, and its debt-to-equity ratio is 0.0, indicating a conservative leverage profile. Despite this strong liquidity position, the company reported a net loss of ¥127,117,000 and an operating loss of ¥128,168,000 in the latest period.

Profitability metrics show significant underperformance relative to industry norms. The company's return on equity (ROE) is -2.69%, and return on assets (ROA) is -2.52%, both of which are negative and suggest operational inefficiencies or declining demand for its services. Gross profit of ¥37,226,000 is significantly lower than revenue of ¥42,713,000, indicating high cost pressures or low pricing power.

The company's revenue is concentrated in a single business segment, as no segmental breakdown is disclosed in the available data. Geographically, Susmed Inc's exposure is not explicitly detailed, but the absence of segmental or geographic diversification increases concentration risk.

Looking ahead, the company's growth trajectory is uncertain. No specific revenue growth rates or outlooks are provided in the available data, and the operating and net losses suggest a challenging near-term path. Analysts have issued a mean recommendation of 2.00, indicating a "buy" rating, but the lack of strong buy or hold ratings suggests limited confidence in the company's near-term prospects.

Risk factors include the company's negative earnings and the potential for future dilution, although the current dilution risk is assessed as low. No immediate filing-based liquidity or dilution flags were detected, but the company's negative operating income raises concerns about its ability to sustain operations without external financing.

Recent events include the publication of the latest financial data, which shows a significant operating and net loss. No recent filings or transcripts were provided in the available data to indicate strategic shifts or operational changes.

Revenue grew 35.1% year-over-year to JPY 463 million, demonstrating strong top-line expansion momentum.

The company maintains zero long-term debt, providing a pristine balance sheet with no leverage risk.

Net losses improved 16.5% year-over-year, indicating a positive trend in profitability despite remaining negative.

A single analyst assigns a buy rating with a target price implying 275% upside potential.

Dilution and liquidity risks are assessed as low, suggesting stable capital structure and market access.

The company reported a net loss of JPY 298 million, resulting in a negative net margin of -2.98%.

Free cash flow remains deeply negative at JPY -310 million, highlighting significant cash burn issues.

Operating and net margins rank in the bottom quartile compared to the IT Services cohort median.

Return on equity is negative at -2.69%, failing to generate value for shareholders relative to book value.

Credit risk is flagged as high, potentially impacting the company's ability to secure favorable financing terms.